Skip to content

Concentration Risk % at other companies

Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
Innoviva, Inc. logo
Innoviva, Inc.INVA
36%+7.0pp
Strattec Security logo
Strattec SecuritySTRT
0.5%0.0pp

Segments

By segment

See full
Income Properties68%-18.1%

By geography

See full
TX14%

Other financials

Income statement

See full
Revenue$18.4M+29.6%
Operating income$6.6M+192%
Net income$2.2M+285%
EPS (diluted)$0.06+175%

Balance sheet

See full
Cash & equivalents$2.6M-57.3%
Total debt$362.5M+0.8%
Total equity$312.5M+29.7%
Total assets$745.1M+15.1%

Cash flow

See full
Operating cash flow$4.4M-25.2%

Valuation

See full
Market cap$334.63M+56.4%
Enterprise value$694.49M+22.4%
P/S5.2×+1.2×

Profitability

See full
Operating margin27%+1.6pp
Net margin6.7%-9.6pp

Returns & leverage

See full
Return on equity1.3%-1.7pp
Debt / equity1.2×-0.3×